E3 PreliminaryPreliminaryPEM unclearMechanisticPeer-reviewedMachine draft
Characterization of Cortisol Dysregulation in Fibromyalgia and Chronic Fatigue Syndromes: A State-Space Approach.
Pednekar, Divesh Deepak, Amin, Md Rafiul, Azgomi, Hamid Fekri et al. · IEEE transactions on bio-medical engineering · 2020 · DOI
Quick Summary
This study looked at how the stress hormone cortisol behaves differently in people with fibromyalgia and ME/CFS compared to healthy people. Researchers found that people with fibromyalgia clear cortisol from their bodies more slowly, causing it to build up, which then triggers the body to reduce cortisol release. People with ME/CFS show different patterns, particularly releasing less cortisol in the early morning hours.
Why It Matters
Understanding distinct cortisol dysregulation patterns in ME/CFS versus fibromyalgia could enable differentiation between these often-confused conditions and guide development of targeted hormonal therapies. This mechanistic characterization moves beyond simple cortisol level measurements to examine dynamic secretion patterns relevant to pathophysiology.
Observed Findings
- FMS patients have lower cortisol clearance rates compared to matched healthy controls
- FMS patients show lower number, magnitude, and energy of cortisol secretory events
- CFS patients demonstrate higher magnitude and energy of secretory events during early morning hours
- CFS and FMS exhibit distinct cortisol alteration patterns, suggesting different underlying mechanisms
Inferred Conclusions
- Lower cortisol clearance in FMS leads to cortisol accumulation, which triggers inhibitory feedback that suppresses further cortisol secretion
- CFS and FMS represent pathophysiologically distinct conditions with measurably different cortisol dynamics
- Cortisol dysregulation patterns may serve as biomarkers to differentiate FMS from CFS and guide treatment development
Remaining Questions
- Do these cortisol dysregulation patterns correlate with symptom severity or specific symptom clusters in either condition?
- Can interventions that correct these dysregulation patterns (e.g., adjusting cortisol feedback) improve clinical outcomes?
- Are the observed cortisol patterns primary drivers of pathophysiology or secondary manifestations of underlying disease mechanisms?
What This Study Does Not Prove
This study does not establish whether cortisol dysregulation causes ME/CFS symptoms or is a consequence of the disease. The research is based on mathematical modeling of cortisol dynamics and does not establish clinical causation, treatment efficacy, or whether correcting cortisol patterns would improve symptoms.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1109/TBME.2020.2978801
- PMID
- 32149617
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →